Reasons still no clearer in wake of FDA approval of Njoy menthol e-cig products

As the smoke from the unexpected approval of Njoy’s menthol e-cigarette products continues to dissipate, it is no clearer whether the decision by the US Food and Drug Administration (FDA) was down to science or politics.

For its part, the FDA insists its decision was solely influenced by the science presented in support of Njoy’s premarket tobacco product application (PMTA).

Read full article
I'm already a subscriber
Author default picture

ECigIntelligence

This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization